3.0
Mar 11, 2024
Recommend
CEO approval
Business Outlook
Pros
Lots of opportunity if you can find a niche, people really do want to do the best science and what is best for patients.
Cons
Ill defined roles leads to toxic turf wars and junior staff used in political fights of upper management. Neuro is risky and Biogen doesn't have the long-term revenue to keep all these programs afloat. Upper management is laser focused on short-term profits and operating expenses.